SOLASTA® Bio Expands Patent Portfolio and Reports Strong Global Field Trial Results
SOLASTA® Bio now holds 14 granted patents for its peptide-based bioinsecticides, including eight in the U.S. and six in Europe.
SOLASTA® Bio now holds 14 granted patents for its peptide-based bioinsecticides, including eight in the U.S. and six in Europe.
Bethnal Green Ventures has led the pre-seed funding round for Ostara, a company developing real-time optimization software for controlled environment agriculture (CEA).
To provide the best experience, we use technologies like cookies to store and access device information.